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ABSTRACT 
 
Objective. To develop the OMERACT thumb base osteoarthritis MRI scoring system (TOMS) for 
assessment of inflammatory and structural abnormalities in this hand osteoarthritis subset, and test 
its cross-sectional reliability. 
 
Methods. Included features and their scaling were agreed upon by members of the OMERACT MRI 
Task Force, using the Hand Osteoarthritis MRI scoring system (HOAMRIS) as a template. A reliability 
exercise was performed, in which 3 readers participated, using a preliminary atlas with examples to 
facilitate reading. Each reader independently scored a set of 20 MRIs (coronal and axial T1- and T2-
weighted fat-suppressed images, of which 5 included T1-weighted fat-suppressed post-Gadolinium 
images). Intra- and inter-reader reliability were assessed using intra-class correlation coefficients 
(ICC) and percentage exact and close agreement (PEA, PCA). 
 
Results. The TOMS assessed the first carpometacarpal (CMC-1) and scaphotrapeziotrapezoid (STT) 
joints for synovitis, subchondral bone defects (including erosions, cysts and bone attrition), 
osteophytes, cartilage and bone marrow lesions on a 0-3 scale (normal to severe). Subluxation was 
only evaluated in CMC-1 joint (absent/present). Reliability of scoring for both joints was comparable. 
Inter-reader ICCs were good for all features (0.77-0.99 and 0.74-0.96 for CMC-1 and STT-joints 
respectively).  Intra-reader reliability analyses gave similar results. PCA ǁĂƐA? ? ?A?ĨŽƌĂůůĨĞĂƚƵƌĞƐ. 
PEA was low to moderate, with better performance for subchondral bone defects, subluxation and 
bone marrow lesions.  
 
Conclusions. A thumb base osteoarthritis MRI scoring system has been developed. The OMERACT 
TOMS demonstrated good intra- and inter-reader reliability. Longitudinal studies are warranted to 
investigate reliability of change scores and responsiveness. 
 
  
What is new: 
x The OMERACT MRI Task Force proposed the first thumb base MRI scoring system 
(TOMS) to assess inflammatory and structural abnormalities in thumb base OA; 
x The OMERACT TOMS demonstrated good intra- and inter-reader reliability in a cross-
sectional reliability exercise.  
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INTRODUCTION 
Hand osteoarthritis (OA) affects the interphalangeal (IP) joints and the thumb base, including the 
first carpometacarpal (CMC-1) and scaphotrapeziotrapezoid (STT) joints(1). Thumb base OA may 
comprise a separate hand OA subset, with distinct risk factors(1). However, much is unknown about 
the pathophysiology and disease course of hand OA subsets. New imaging modalities including 
magnetic resonance imaging (MRI) with visualization of all affected joint compartments may lead to 
increased insights into this disease. 
Previously, the Hand Osteoarthritis MRI scoring system (HOAMRIS) for IP OA was developed, with 
good cross-sectional and moderate longitudinal reliability(2, 3). However, although the thumb base 
is commonly affected in hand OA patients(4), no MRI scoring systems assessing these joints exist to 
date. MRI studies of the thumb base of hand OA patients can contribute to the understanding of this 
disease subset, including its differences and similarities with IP OA. 
The aim was to develop the OMERACT thumb base OA MRI scoring system (TOMS) for assessment of 
inflammatory and structural abnormalities in thumb base OA, and to test its cross-sectional 
reliability using OMERACT methodology(5, 6).  
 
 
METHODS 
Development of the OMERACT TOMS 
Using HOAMRIS as template, members of the OMERACT MRI Task Force iteratively discussed the 
joints and features (including definitions and scaling) to be included, as well as a list of preferred 
sequences and planes, in several Web-based meetings, and agreed by consensus. 
Table 1 provides an overview of the proposed MRI features. Each feature was evaluated on 0-3 
scales in the CMC-1 and STT-joints, except subluxation, which was scored absent/present in the 
CMC-1 joint only. The proximal and distal joint parts were scored separately for subchondral bone 
defects, osteophytes, and bone marrow lesions (BMLs). For CMC-1, the proximal part of the first 
metacarpal bone (MC-1) (from the articular surface to a 1 cm depth) and distal half of the trapezium 
were evaluated (range 0-6); for STT, the proximal half of the trapezium and trapezoid and the distal 
half of the scaphoid were scored (range 0-9). Increments of 0.5 were introduced for synovitis, 
subchondral bone defects and BMLs to increase potential responsiveness of the score. 
 
Reliability exercise 
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A reliability exercise was conducted by two rheumatologists (VF, FG) and one radiologist (CP) with 
extensive experience in assessing hand/wrist MRIs. Two readers (VF, FG) repeated the exercise after 
one month after recoding and rearrangement of MRIs in a different order. A preliminary atlas with 
examples of most grades of each feature was developed prior to the exercise, approved by the 
members of the Task Force and distributed among readers to facilitate scoring. Each reader scored 
20 MRIs: 15 MRIs were acquired on a 1.5T extremity MRI unit (ONI, GE, Wisconsin, USA) in hand OA 
patients from the Hand Osteoarthritis in Secondary Care (HOSTAS) study at Leiden University 
Medical Center (Leiden, Netherlands), and 5 MRIs were acquired on a 3.0T MRI unit (Philips Ingenia) 
in hand OA patients from Sheba Medical Center (Tel Aviv, Israel). MRIs were selected by a non-
reader to include a wide range of severity of pathology in the thumb base (based on Kellgren-
Lawrence scores). MRIs from HOSTAS included coronal and axial T1-weighted (T1w) fast spin echo 
(FSE), and T2w FSE images with fat-saturation (fs) (Supplementary file). MRIs from Sheba Medical 
Center additionally included coronal and axial T1w-fs post-Gadolinium (Gd) images. A general wrist 
acquisition was used. Data collection in both centers was approved by the local ethics committee. All 
HOSTAS participants signed informed consent; written consent was waved for use of MRIs from 
Sheba Medical Center. 
 
Statistical analysis 
Each MRI feature was analysed separately for the CMC-1 and STT-joints. Separate scores for the 
distal and proximal joint parts were combined into a single sum score per joint where appropriate. 
Median and interquartile range (IQR) were calculated for each feature based on the mean value of 
the three readers. Reliability was assessed by calculating intra-class correlation coefficients (ICCs) 
and percentage exact and close agreement (PEA/PCA). Single and average measure ICCs (mixed 
effect models, absolute agreement) were calculated to assess intra- and inter-reader reliability, 
ƌĞƐƉĞĐƚŝǀĞůǇ ?/ǀĂůƵĞƐA?0.20 were considered as poor,  ? ? ? ?A?/A? ? ? ? ?ĂƐĨĂŝƌ ? ? ? ? ?A?/A?0.60 as 
moderate, 0 ? ? ?A?/A? ? ? ? ?ĂƐŐŽŽĚ ?ĂŶĚ/A?0.80 as very good reliability(7). PEA was defined as a 
difference of 0 between minimum and maximum scores across readers, and PCA as a difference of 
A? ?ďĞƚǁĞĞŶŵŝŶŝŵƵŵĂŶĚŵaximum scores. 
 
 
RESULTS 
Supplementary Table 1 shows characteristics of the 15 HOSTAS patients. Most MRI features were 
present in the majority of patients (Table 2). STT-joint scores were overall lower compared to CMC-
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1, despite higher possible score range for certain features. Time required to perform TOMS was 
comparable to that required to score two joints with HOAMRIS. 
All features demonstrated good to very good inter-ƌĞĂĚĞƌ/ǀĂůƵĞƐ ?dĂďůĞ ? ? ?WǁĂƐA? ? ?A?ĨŽƌĂůů
features. PEA was low to moderate, with better performance for subchondral bone defects, 
subluxation and BMLs. Similar results were found for intra-reader reliability (Supplementary Table 
2). Reliability of the CMC-1 and STT-joints were generally comparable. 
When analysing the reliability of subchondral bone defects, osteophytes and BMLs for the distal and 
proximal joint parts separately, we generally saw comparable ICCs to the aggregated scores. 
However, for subchondral bone defects in the trapezoid and osteophytes in the trapezoid and the 
proximal side of the trapezium, ICCs were moderate (data not shown). 
Readers gave slightly higher scores when assessing synovitis on post-Gd images as compared to the 
T2w-fs images (data not shown), whereas reliability was comparable (CMC-1: ICC [95% CI] 0.75 
[0.05-0.97] versus 0.83 [0.59-0.94], and STT 0.68 [-0.37-0.96] versus 0.78 [0.47-0.92] for images with 
versus without Gd). 
  
 
DISCUSSION 
In this study the OMERACT MRI Task Force proposed the first thumb base MRI scoring system, 
TOMS, and evaluated its cross-sectional reliability. The score was feasible and had good to very good 
reliability for assessment of structural and inflammatory features in the CMC-1 and STT-joint. 
The previously published OMERACT HOAMRIS for the IP joints was used as a prototype in the 
development of the TOMS(3). Two major differences between the scoring systems can be noted. 
First, erosive damage and cysts were combined into one score (subchondral bone defects), because 
it was judged that the distinction could not be made reliably in the thumb base joints. Second, due 
to larger joint size, it was reasoned that direct cartilage assessment is feasible in the thumb base 
when using appropriate MRI sequences, and should be prioritized over indirect cartilage assessment. 
Furthermore, it was decided to score distal and proximal joint parts separately for some features, 
similar to the first Oslo MRI scoring system for IP OA(8). Since only two joints are evaluated, this 
addition provides more detailed information without decreasing feasibility. In future studies of 
pharmacological and non-pharmacological interventions, HOAMRIS and TOMS can be used as 
complimentary scoring systems, since both assess similar features. Combined assessment of the 
fingers and thumb base of hand OA patients with MRI in future trials can provide information about 
hypothesized differences in the pathophysiology of these OA subtypes(1).  
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Assessment of the scaphotrapezoid articulation was also included in the scoring system. Previous 
cadaver studies have shown frequent degenerative changes of the scaphotrapezoid joint, although 
its relative contribution to STT-joint OA complaints is unclear, partly because of poor visualization 
with traditional radiography(9, 10).  
All MRIs included were performed using a standard wrist acquisition technique. Although dedicated 
thumb base acquisitions do exist, these are not widely used in clinical practice. It is unclear whether 
the use of a dedicated thumb base acquisition would yield different results, and this should be 
evaluated in future studies. 
Only five MRIs included post-Gd imaging. No previous studies have compared the reliability and 
validity of MRI-defined synovitis with and without contrast in hand OA patients. In knee OA synovitis 
is commonly assessed without contrast, although contrast-enhanced MRI appears to be a more 
reliable and valid measure of synovial inflammation, with the ability to differentiate inflamed 
synovium from effusion(11, 12). Østergaard et al. found that omitting contrast from MRI 
examination of synovitis in the metacarpophalangeal and wrist joints in rheumatoid arthritis patients 
decreased reliability(13). In our sample reliability was good using both contrast and non-contrast 
images. This warrants more detailed exploration, preferably comparing synovitis scores between 
different sequences within the same patient in a larger sample. 
Before TOMS can be recommended as core instrument according to the OMERACT filter(6), 
assessment of the reliability of change scores and its responsiveness in longitudinal studies is 
needed. Future studies will reveal whether reliability of TOMS is similar when used by other trained 
readers compared to expert readers who developed the scoring system, which for HOAMRIS was 
shown to be either better or worse(14,15). Furthermore, readers used a preliminary atlas during the 
exercises, which has likely increased agreement across readers, as was previously shown for 
HOAMRIS(3). A comprehensive atlas including all grades of all features in both joints would facilitate 
scoring and increase reliability of the TOMS. Validity of the scoring system should be investigated in 
future studies, by assessing correlations with signs and symptoms, and other imaging modalities, 
including traditional radiography and ultrasound. 
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Table 1. Definitions and scaling of features in proposed OMERACT thumb base osteoarthritis MRI scoring system 
MRI feature Definition Scaling* Advised plane and 
MRI sequence 
Synovitis ? Thickened synovium with 
enhancement after Gd injection. 
0= normal; 1= mild (1-33%); 2= 
moderate (34-66%); 3= severe (67-
100%). Based on thirds of the presumed 
maximum thickness of enhancing tissue 
in the synovial compartment.  
Coronal and axial. 
T1w pre- and post-Gd 
with fs. In absence of 
post-Gd images T2w-
fs/STIR/PD-fs can be 
used. 
Subchondral 
bone defects ?# 
Subchondral bone loss, including 
erosions (sharply marginated bone 
lesions with cortical break), cysts 
(sharply marginated bone lesions 
without cortical break) and bone 
attrition (diffuse loss of bone 
contour). 
 ?A?ŶŽďŽŶĞĚĞĨĞĐƚƐ ? ?A?ŵŝůĚ ?A? ? ?A?ŽĨ
bone volume or joint surface affected); 
2= moderate (26-50% of bone volume or 
joint surface affected); 3= severe (>50% 
of bone volume or joint surface 
affected). 
Coronal and axial. 
T1w and T2w-
fs/STIR/PD-fs. 
Osteophytes# Abnormal bone protuberance at 
joint margins or surfaces. 
0= no osteophytes; 1= mild (1-2 small 
ŽƐƚĞŽƉŚǇƚĞƐ ? ? ?A?ŵŽĚĞƌĂƚĞ ?A? ?ƐŵĂůů
ŽƐƚĞŽƉŚǇƚĞƐĂŶĚ ?ŽƌA䠃?ŵŽĚĞƌĂƚĞ
ŽƐƚĞŽƉŚǇƚĞ ?Ɛ ? ? ? ?A?ƐĞǀĞƌĞ ?A? ?ůĂƌŐĞ
osteophyte(s). 
Coronal (and sagittal if 
available). 
T1w. 
Cartilage 
assessment 
Loss of cartilage, or loss of cartilage 
space based on the inter-bone 
distance.* 
[*If assessment of cartilage and 
cartilage space are in conflict, direct 
visualization of the cartilage should 
be prioritized] 
0= no loss of cartilage or cartilage space; 
1= mild (cartilage loss without complete 
denuding, or cartilage space loss 
without bone-to-bone contact); 2= 
moderate (cartilage loss with denuding 
A? ? ?A?ŽĨũŽŝŶƚƐƵƌĨĂĐĞŽƌĨŽĐĂůĐŽŵƉůĞƚĞ
cartilage space loss with bone-to-bone 
ĐŽŶƚĂĐƚA? ? ?A?ŽĨƚŚĞĂƌƚŝĐƵůĂƚŝŶŐĂƌĞĂ ? ?
3= severe (cartilage loss with denuding 
>50% of joint surface or complete 
cartilage space loss over >50% of the 
articulating area. 
Coronal. 
T1w-fs-3D-GE, otherwise 
use T1w-fs, T2w-fs or PD-
fs. 
Subluxation^ Subluxation of the CMC-1 joint in the 
frontal plane. 
0= MC-1 subluxed 0-25% of the MC-
width; 1= MC- ?ƐƵďůƵǆĞĚA䠃? ?A?ŽĨƚŚĞ
MC-width. 
Coronal. 
T1w. 
Bone marrow 
lesions ?# 
Lesions within the trabecular bone 
with signal characteristic consistent 
with increased water content* and 
with ill-defined margins. 
[*High signal intensity on STIR/T2w-
fs images] 
0= no bone marrow lesions; 1= mild (1-
33%); 2= moderate (34-66%); 3= severe 
(67-100%). Based on thirds of assessed 
bone volume. 
Coronal and axial. 
T2w-fs/STIR/PD-fs. 
 ?In longitudinal studies, 0.5 increments may be used for synovitis, subchondral bone defects, and bone marrow lesions. 
#Proximal and distal parts of joint are scored separately for subchondral bone defects, osteophytes and bone marrow 
lesions. ^Only the CMC-1 joint is evaluated for this feature. CMC-1, first carpometacarpal joint. fs, fat saturated. Gd, 
gadolinium. GE, gradient echo. MC-1, first metacarpal. PD, proton density. w, weighted. 
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Table 2. Median (interquartile range) scores of each MRI feature and number of patients (%) 
with each feature present for the CMC-1 and STT joint (n=20). 
MRI feature [range for CMC-1/STT] CMC-1 joint STT joint 
 median (IQR)  n(%) median (IQR) n(%) 
Synovitis [0-3/0-3] 1.4 (1.0-2.3) 20 (100) 1.0 (0.4-1.7) 18 (90) 
Subchondral bone defects [0-6/0-9] 1.4 (1.0-2.8) 18 (90) 1.0 (0.3-2.0) 17 (85) 
Osteophytes [0-6/0-9] 2.2 (1.2-4.0) 19 (95) 0.3 (0.0-0.9) 13 (65) 
Cartilage assessment [0-3/0-3] 1.5 (0.4-2.3) 16 (80) 1.0 (0.4-1.3) 16 (80) 
Subluxation [absent or present]  12 (60)   
Bone marrow lesions [0-6/0-9] 1.7 (0.0-3.8) 13 (65) 1.4 (0.1-2.9) 15 (75) 
Separate scores for the distal and proximal part of the joint were combined into a single sum score per 
joint. Number (%) of patients with each feature present in at least one of three readers. CMC-1, first 
carpometacarpal. IQR, interquartile range. MRI, magnetic resonance imaging. n, number. STT, 
scaphotrapeziotrapezoid. 
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Table 3. Inter-reader reliability of MRI features for the CMC-1 and STT joint (3 readers). 
 CMC-1 joint STT joint 
 AvmICC 
(95% CI) 
PEA 
n/N (%) 
PCA 
n/N (%) 
AvmICC 
(95% CI) 
PEA 
n/N (%) 
PCA 
n/N (%) 
Synovitis 0.81 (0.60-0.92) 3/20 (15) 15/20 (75) 0.75 (0.48-0.90) 7/20 (35) 18/20 (90) 
Subchondral bone 
defects 
0.88 (0.73-0.95) 23/40 (58) 36/40 (90) 0.81 (0.60-0.92) 42/60 (70) 58/60 (97) 
Osteophytes 0.83 (0.56-0.93) 10/40 (25) 31/40 (78) 0.74 (0.44-0.89) 41/60 (68) 56/60 (93) 
Cartilage assessment 0.79 (0.48-0.92) 6/20 (30) 13/20 (65) 0.83 (0.64-0.93) 8/20 (40) 16/20 (80) 
Subluxation 0.77 (0.52-0.91) 13/20 (65)     
Bone marrow lesions 0.99 (0.98-1.00) 32/40 (80) 40/40 (100) 0.96 (0.91-0.98) 43/60 (72) 57/60 (95) 
Separate scores for the distal and proximal part of the joint were combined into a single sum score per joint to calculate 
ICCs. AvmICC, average measure intra-class correlation coefficient. CI, confidence interval. CMC-1, first carpometacarpal. 
IQR, interquartile range. MRI, magnetic resonance imaging. N, number. PCA, percent close agreement. PEA, percent exact 
agreement. STT, scaphotrapeziotrapezoid. 
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ONLINE SUPPLEMENTARY FILE 
 
Additional MRI sequence information HOSTAS 
MRIs from the HOSTAS study included T1-weighted (T1w) fast spin echo (FSE) images in coronal and 
axial planes (TR/TE 575/11.2, slice thickness 2.0 and 3.0 mm, slice gap 0.2 and 0.3 mm), and T2w FSE 
images with frequency-selective fat-saturation in coronal and axial planes (TR/TE 3000/61.8, slice 
thickness 2.0 and 3.0 mm, slice gap 0.2 and 0.3 mm). 
 
 
Supplementary table 1. Demographic and clinical characteristics of HOSTAS patients included 
in the reliability exercise (n=15). 
 Patients in exercise (n=15)* 
Women, n (%) 12 (80%) 
Age, mean (SD) years 65.3 (9.0) 
Body mass index, mean (SD) kg/m2 29.6 (5.4) 
Kellgren-Lawrence grade CMC-1 ?#, n (%) 
Grade 1 
Grade 2 
Grade 3 
Grade 4 
 
5 (36%) 
5 (36%) 
3 (21%) 
1 (7%) 
Grip strength ? ?ŵĞĂŶ ?^ ?ŬŐ 23.4 (8.3) 
AUSCAN pain, mean (SD) [0-20] 8.9 (3.2) 
AUSCAN function, mean (SD) [0-36] 14.3 (5.5) 
VAS pain ? ?ŵĞĂŶ ?^ ? ? ?-100] 36.4 (20.6) 
Self-reported joint pain thumb ?, n(%) 11 (73%) 
Self-reported joint stiffness thumb ?, n(%) 7 (47%) 
Bony swelling CMC-1 joint ? ?Ŷ ?A? ? 5 (33%) 
Tenderness on palpation CMC-1 joint ?, n(%) 7 (47%) 
Limited range of motion CMC-1 ?, n(%) 4 (27%) 
*Information only available for patients from the HOSTAS cohort.  ?KŶůǇĚĂƚĂŽĨƚŚĞŝŵĂŐĞĚŚĂŶĚĂƌĞ
displayed. #Data from n=14 patients. AUSCAN, Australian/Canadian hand osteoarthritis index. CMC-1, 
first carpometacarpal. kg, kilogram. n, number. SD, standard deviation. 
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Supplementary table 2. Intra-reader reliability of MRI features for the CMC-1 and STT joint 
(2 readers). 
 CMC-1 joint STT joint 
 SmICC PEA (%) PCA (%) SmICC PEA (%) PCA (%) 
Synovitis 0.53-0.83 65 90-95 0.72-0.89 65-90 100 
Subchondral bone defects 0.89-0.89 95 100 0.62-0.70 90-95 100 
Osteophytes 0.71-0.73 60-70 100 0.44-0.71 90-100 100 
Cartilage assessment 0.61-0.86 75 95-100 0.71-0.84 65-70 100 
Subluxation 0.53-0.91 80-95     
Bone marrow lesions 0.98-0.96 100 100 0.87-0.92 95 100 
Values of both readers shown separately (lowest-highest), unless values were not different. Separate 
scores for the distal and proximal part of the joint were combined into a single sum score per joint to 
calculate ICCs. CI, confidence interval. CMC-1, first carpometacarpal. IQR, interquartile range. MRI, 
magnetic resonance imaging. N, number. PCA, percent close agreement. PEA, percent exact 
agreement. SmICC, single measure intra-class correlation coefficient. STT, scaphotrapeziotrapezoid. 
 
 
